Chaperono- und Proteinopathien: molekulare Grundlagen - künftige Therapien

Chaperonopathien - Proteinopathien

chaperonopathies - proteinopathies

Literatur

• 1 Ansar S, Burlison J A, Hadden M K. et al . A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity.  Bioorg Med Chem Lett. 2007;  17 (7) 1984-90
• 2 Barral J M, Broadley S A, Schaffar G, Hartl F U. Roles of molecular chaperones in protein misfolding diseases.  Semin Cell Dev Biol. 2004;  15 (1) 17-29
• 3 Bence N F, Sampat R M, Kopito R R. Impairment of the ubiquitin-proteasome system by protein aggregation.  Science. 2001;  292 (5521) 1552-5
• 4 Di Tommaso L, Franchi G, Park Y N. et al . Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.  Hepatology. 2007;  45 (3) 725-34
• 5 Greiner J, Ringhoffer M, Taniguchi M. et al . Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia.  Int J Cancer. 2003;  106 (2) 224-31
• 6 Macario A J, Macario de Conway E. Chaperonopathies and chaperonotherapy.  FEBS Lett. 2007;  581 (19) 3681-8
• 7 Macario A J, Macario de Conway E. Chaperonopathies by defect, excess, or mistake.  Ann N Y Acad Sci. 2007;  1113 178-91
• 8 Macario A J, Macario de Conway E. Molecular chaperones: multiple functions, pathologies, and potential applications.  Front Biosci. 2007;  12 2588-600
• 9 Macario A J, Macario de Conway E. Sick chaperones and ageing: a perspective.  Ageing Res Rev. 2002;  1 (2) 295-311
• 10 Macario A J, Macario de Conway E. Sick chaperones, cellular stress, and disease.  N Engl J Med. 2005;  353 (14) 1489-501
• 11 Macario A J, Macario de Conway E. Stress and molecular chaperones in disease.  Int J Clin Lab Res. 2000;  30 (2) 49-66
• 12 Macario A J, Macario de Conway E. The pathology of cellular anti-stress mechanisms: a new frontier.  Stress. 2004;  7 (4) 243-9
• 13 Otto H, Conz C, Maier P. et al . The chaperones MPP11 and Hsp70L1 form the mammalian ribosome-associated complex.  Proc Natl Acad Sci U S A. 2005;  102 (29) 10 064-9
• 14 Pacey S, Banerji U, Judson I, Workman P. Hsp90 inhibitors in the clinic.  Handb Exp Pharmacol. 2006;  (172) 331-58
• 15 Selkoe D J. Folding proteins in fatal ways.  Nature. 2003;  426 (6968) 900-4
• 16 Slavotinek A M, Biesecker L G. Unfolding the role of chaperones and chaperonins in human disease.  Trends Genet. 2001;  17 (9) 528-35
• 17 Sreedhar A S, Csermely P. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review.  Pharmacol Ther. 2004;  101 (3) 227-57
• 18 Young J C, Agashe V R, Siegers K, Hartl F U. Pathways of chaperone-mediated protein folding in the cytosol.  Nat Rev Mol Cell Biol. 2004;  5 (10) 781-91